Memantine in Preventing Side Effects in Patients Undergoing Whole-Brain Radiation Therapy for Brain Metastases From Solid Tumors

NCT00566852 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

554

Enrollment

NETWORK

Sponsor class

Conditions

Cognitive/Functional Effects
Metastatic Cancer
Neurotoxicity
Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG: Memantine
OTHER: Placebo
RADIATION: Whole brain radiation therapy

Sponsor

Radiation Therapy Oncology Group

Collaborators

[object Object]
[object Object]